Provexis (PXS) Competitors GBX 0.64 -0.03 (-4.19%) As of 09:54 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock PXS vs. NSH, ALK, SHIP, TORO, CLCO, ICON, PAA, GEL, MMP, and CCLShould you be buying Provexis stock or one of its competitors? The main competitors of Provexis include Norish (NSH), Alkemy Capital Investments (ALK), Tufton Oceanic Assets (SHIP), Chenavari Toro Income Fund (TORO), CloudCoCo Group (CLCO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), and Carnival Co. & (CCL). These companies are all part of the "transportation" industry. Provexis vs. Its Competitors Norish Alkemy Capital Investments Tufton Oceanic Assets Chenavari Toro Income Fund CloudCoCo Group Iconic Labs 22532 (PAA.L) Greka Engineering & Technology Marwyn Management Partners Carnival Co. & Provexis (LON:PXS) and Norish (LON:NSH) are both small-cap transportation companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment. Does the media prefer PXS or NSH? In the previous week, Provexis' average media sentiment score of 0.00 equaled Norish'saverage media sentiment score. Company Overall Sentiment Provexis Neutral Norish Neutral Do insiders and institutionals believe in PXS or NSH? 7.9% of Provexis shares are held by institutional investors. 11.8% of Provexis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has higher earnings & valuation, PXS or NSH? Norish has higher revenue and earnings than Provexis. Provexis is trading at a lower price-to-earnings ratio than Norish, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProvexis£1.20M12.51-£619.15K-£0.00-2,133.33Norish£36.39M0.00N/A£6.10N/A Is PXS or NSH more profitable? Norish has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Norish's return on equity of 0.00% beat Provexis' return on equity.Company Net Margins Return on Equity Return on Assets Provexis-73.10% -68.68% -56.14% Norish N/A N/A N/A SummaryNorish beats Provexis on 6 of the 8 factors compared between the two stocks. Get Provexis News Delivered to You Automatically Sign up to receive the latest news and ratings for PXS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXS vs. The Competition Export to ExcelMetricProvexisDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£15.01M£1.68B£5.79B£2.58BDividend Yield5.06%2.93%5.69%5.30%P/E Ratio-2,133.3365.3974.595,410.66Price / Sales12.511,297.60453.5496,691.07Price / CashN/A10.3737.0827.93Price / Book74.6111.9112.157.76Net Income-£619.15K£20.70B£3.28B£5.89B7 Day Performance-17.95%0.81%0.99%6.49%1 Month Performance-9.35%3.44%7.21%56.20%1 Year Performance-7.25%4.80%63.07%148.15% Provexis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXSProvexisN/AGBX 0.64-4.2%N/A-7.1%£15.01M£1.20M-2,133.334Gap UpNSHNorishN/AN/AN/AN/A£52.62M£36.39M28.691,251Gap UpALKAlkemy Capital InvestmentsN/AGBX 199.50-3.6%N/A+436.8%£19.65MN/A-1,231.4825,500Gap DownSHIPTufton Oceanic AssetsN/AGBX 1.13+0.3%N/A-13.3%£3.02M£67.20M4.8750TOROChenavari Toro Income FundN/AGBX 0.67+0.8%N/A+27.6%£2.07M£37.05M5.80N/AGap UpCLCOCloudCoCo GroupN/AGBX 0.23-19.3%N/A+152.3%£1.62M£7.79M255.56125Gap UpHigh Trading VolumeICONIconic LabsN/AGBX 2.95+30.9%N/A-53.3%£409KN/A-72.723Gap DownPAA22532 (PAA.L)N/AN/AN/AN/A£0.00N/A0.004,100Gap UpHigh Trading VolumeGELGreka Engineering & TechnologyN/AN/AN/AN/A£0.00N/A0.002,110MMPMarwyn Management PartnersN/AN/AN/AN/A£0.00N/A0.001,660CCLCarnival Co. &N/AGBX 2,136-0.8%N/A+92.3%£28.04B£25.97B1,118.3240,000News CoverageHigh Trading Volume Related Companies and Tools Related Companies Norish Alternatives Alkemy Capital Investments Alternatives Tufton Oceanic Assets Alternatives Chenavari Toro Income Fund Alternatives CloudCoCo Group Alternatives Iconic Labs Alternatives 22532 (PAA.L) Alternatives Greka Engineering & Technology Alternatives Marwyn Management Partners Alternatives Carnival Co. & Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:PXS) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Provexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PXS Stock Alerts